Rita Lin

2.8k total citations · 1 hit paper
22 papers, 2.2k citations indexed

About

Rita Lin is a scholar working on Epidemiology, Hepatology and Rheumatology. According to data from OpenAlex, Rita Lin has authored 22 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 16 papers in Hepatology and 4 papers in Rheumatology. Recurrent topics in Rita Lin's work include Liver Disease Diagnosis and Treatment (17 papers), Hepatitis C virus research (15 papers) and Hepatitis B Virus Studies (6 papers). Rita Lin is often cited by papers focused on Liver Disease Diagnosis and Treatment (17 papers), Hepatitis C virus research (15 papers) and Hepatitis B Virus Studies (6 papers). Rita Lin collaborates with scholars based in Australia, Indonesia and Taiwan. Rita Lin's co-authors include Dev Samarasinghe, Geoffrey C. Farrell, Christopher Liddle, Shivakumar Chitturi, Jacob George, Martin Weltman, Jason M. Hui, Shehan Abeygunasekera, JANE HOLMES-WALKER and Caroline Fung and has published in prestigious journals such as Hepatology, Gut and The Journal of Infectious Diseases.

In The Last Decade

Rita Lin

22 papers receiving 2.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome

2002 936 citations Shivakumar Chitturi, Shehan Abeygunasekera et al. Hepatology profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Rita Lin	1.9k	985	699	296	237	22	2.2k
Dev Samarasinghe	2.0k 1.0×	1.0k 1.0×	706 1.0×	339 1.1×	248 1.0×	22	2.3k
Joel Z. Stengel	1.6k 0.8×	702 0.7×	688 1.0×	299 1.0×	274 1.2×	6	1.9k
Miguel Carneiro de Moura	2.0k 1.0×	1.1k 1.1×	680 1.0×	295 1.0×	367 1.5×	73	2.6k
Terese Haaland	1.2k 0.6×	623 0.6×	437 0.6×	368 1.2×	134 0.6×	17	1.7k
Kittichai Promrat	2.4k 1.2×	1.2k 1.2×	1.1k 1.6×	340 1.1×	311 1.3×	34	2.8k
Glen Lutchman	1.5k 0.8×	745 0.8×	668 1.0×	229 0.8×	186 0.8×	39	1.7k
Elsbeth Henderson	1.9k 1.0×	1.0k 1.0×	769 1.1×	265 0.9×	353 1.5×	12	2.1k
F. Pons‐Romero	1.6k 0.8×	934 0.9×	369 0.5×	346 1.2×	326 1.4×	61	2.1k
Rosa Lombardi	1.1k 0.6×	546 0.6×	419 0.6×	207 0.7×	199 0.8×	73	1.5k
Oreste Lo Iacono	2.1k 1.1×	1.5k 1.5×	256 0.4×	470 1.6×	175 0.7×	60	2.6k

Countries citing papers authored by Rita Lin

Since Specialization

Citations

This map shows the geographic impact of Rita Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rita Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rita Lin more than expected).

Fields of papers citing papers by Rita Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rita Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rita Lin. The network helps show where Rita Lin may publish in the future.

Co-authorship network of co-authors of Rita Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Rita Lin. A scholar is included among the top collaborators of Rita Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rita Lin. Rita Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lin, Rita, Po–Jung Pan, Nai‐Wei Hsu, & Hsi‐Chung Chen. (2023). Associations between Various Sleep-Wake-Related Indicators and Nutritional Status in Community-Dwelling Older Adults: The Yilan Study, Taiwan. The journal of nutrition health & aging. 27(10). 861–867. 1 indexed citations

Wijaya, Ratna Sari, Scott Read, Naomi R. Truong, et al.. (2020). HBV vaccination and HBV infection induces HBV-specific natural killer cell memory. Gut. 70(2). gutjnl–2019. 40 indexed citations

Wijaya, Ratna Sari, Scott Read, Stephen D. Schibeci, et al.. (2019). KLRG1+ natural killer cells exert a novel antifibrotic function in chronic hepatitis B. Journal of Hepatology. 71(2). 252–264. 45 indexed citations

Byth, Karen, Rita Lin, Martin Weltman, et al.. (2004). Effects of Interferon Treatment Response on Liver Complications of Chronic Hepatitis C: 9-year Follow-Up Study. The American Journal of Gastroenterology. 99(4). 636–644. 46 indexed citations

Sud, Archana, Jason M. Hui, Geoffrey C. Farrell, et al.. (2004). Improved prediction of fibrosis in chronic hepatitis C using measures of insulin resistance in a probability index. Hepatology. 39(5). 1239–1247. 139 indexed citations

Lee, David D., Shivakumar Chitturi, James G. Kench, et al.. (2003). Transjugular liver biopsy effecting changes in clinical management. Australasian Radiology. 47(2). 117–120. 8 indexed citations

Samarasinghe, Dev, Rita Lin, James G. Kench, et al.. (2003). Changes in Antipyrine Clearance and Platelet Count, But Not Conventional Liver Tests, Correlate With Fibrotic Change in Chronic Hepatitis C: Value for Predicting Fibrotic Progression. The American Journal of Gastroenterology. 98(6). 1384–1390. 23 indexed citations

Kumar, Dinesh, Craig T. Wallington‐Beddoe, Jacob George, et al.. (2003). Effectiveness of interferon alfa‐2b/ribavirin combination therapy for chronic hepatitis C in a clinic setting. The Medical Journal of Australia. 178(6). 267–271. 18 indexed citations

Chitturi, Shivakumar, Martin Weltman, Geoffrey C. Farrell, et al.. (2002). HFE mutations, hepatic iron, and fibrosis: Ethnic-specific association of NASH with C282Y but not with fibrotic severity. Hepatology. 36(1). 142–149. 184 indexed citations

10.

Hui, Jason M., Jacob George, Christopher Liddle, et al.. (2002). Changes in serum albumin during treatment of chronic hepatitis B with lamivudine: effects of response and emergence of drug resistance. The American Journal of Gastroenterology. 97(4). 1003–1009. 12 indexed citations

11.

Chitturi, Shivakumar, Shehan Abeygunasekera, Geoffrey C. Farrell, et al.. (2002). NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology. 35(2). 373–379. 936 indexed citations breakdown →

12.

Hui, Jason M., James G. Kench, Geoffrey C. Farrell, et al.. (2002). Genotype‐specific mechanisms for hepatic steatosis in chronic hepatitis C infection. Journal of Gastroenterology and Hepatology. 17(8). 873–881. 140 indexed citations

13.

Chitturi, Shivakumar, Geoffrey C. Farrell, Linda Frost, et al.. (2002). Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: A manifestation of lipotoxicity?. Hepatology. 36(2). 403–409. 293 indexed citations

14.

Farrell, Geoffrey C., Karen Byth, Rita Lin, et al.. (2000). Which patients with hepatitis C develop liver complications?. Hepatology. 31(2). 513–520. 135 indexed citations

15.

Dutta, Usha, James G. Kench, Karen Byth, et al.. (1998). Hepatocellular proliferation and development of hepatocellular carcinoma: A case-control study in chronic hepatitis C. Human Pathology. 29(11). 1279–1284. 31 indexed citations

16.

Lin, Rita, et al.. (1995). Interferon alfa-2b for chronic hepatitis C: effects of dose increment and duration of treatment on response rates. Journal of Hepatology. 23(5). 487–496. 107 indexed citations

17.

Byth, Karen, et al.. (1995). Antipyrine clearance and response to interferon treatment in patients with chronic active hepatitis C. Hepatology. 22(4). 1065–1071. 18 indexed citations

18.

Farrell, Geoffrey C., et al.. (1993). Epidemiology of hepatitis C virus infection in Australia. Gastroenterologia Japonica. 28(S5). 32–36. 14 indexed citations

19.

Lin, Rita, et al.. (1993). Alpha-interferon 2b in the treatment of chronic hepatitis C: interim report of the first multicentre Australian trial. Gastroenterologia Japonica. 28(S5). 101–103. 4 indexed citations

20.

Farrell, Geoffrey C., et al.. (1991). Prediction of response to interferon in patients with chronic active hepatitis C, and evidence that this improves hepatic metabolic function. Gastroenterologia Japonica. 26(S3). 243–246. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact